摘要
2020年6月,欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)指南委员会正式发布了2020版ESMO胃肠胰神经内分泌肿瘤的诊治和随访指南,该指南从流行病学、病理和分子诊断、分期和风险评估、局部病变的治疗、进展期病变的治疗、随访等方面进行了系统说明,在每部分后面均有总结性的推荐要点,整体内容较2012版指南有较大变化,本文将对该指南进行解读。
In June 2020,the European Society for Medical Oncology(ESMO)Guidelines Committee officially released the 2020 version of the guideline for the diagnosis,treatment and follow-up of gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs).Epidemiology,pathological and molecular diagnosis,staging and risk assessment,treatment of regional or advanced disease and follow-up have been systematically described in this guideline.There are summarized recommendations in the end of each part.The overall content is quite different from the 2012 version of the guideline.This paper will interpret the 2020 ESMO guideline.
作者
李洁
Li Jie(Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China)
出处
《肿瘤综合治疗电子杂志》
2020年第3期16-26,共11页
Journal of Multidisciplinary Cancer Management(Electronic Version)
关键词
胃肠胰神经内分泌肿瘤
胰腺神经内分泌肿瘤
小肠神经内分泌肿瘤
诊断
治疗
随访
Gastroenteropancreatic neuroendocrine neoplasms
Pancreatic-neuroendocrine neoplasms
Small intestinalneuroendocrine neoplasms
Diagnosis
Treatment
Follow-up
